OpenVSafe by OpenVAERS
Search V-safe

ZXA-15698-19400

2 vaccinations 2 coded responses 17 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
770 / TX
Registered
2021-11-17
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino
Registered dependents
KAG-29271-74544 Child or adolescent in my care · Female · 2021-12-10
Q8Q-21858-37676 Child or adolescent in my care · Male · 2021-12-10

Timeline

  1. 2021-11-17
    Registered in v-safe
  2. 2021-11-17
    Dose 1 — Pfizer-BioNTech
  3. 2021-11-17
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-11-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  5. 2021-11-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-11-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-11-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-11-24
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-12-01
    Survey response — day 14, dose 1
    MedDRA: Cough, Head discomfort, Headache, Nasal congestion, Nasopharyngitis, Sneezing — Feeling: Good
    Free text: Minor head cold symptoms like nasal stuffyness, headache and pressure, sneezing and coughing. Lasted only a few days.
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-08
    Dose 2 — Pfizer-BioNTech
  11. 2021-12-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  12. 2021-12-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-12-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-12-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-12-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-12-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-01-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-01-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-01-17
    Survey response — day 35, dose 2
    MedDRA: Nasal congestion, Productive cough, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Minor fever, nasal congestion and coughing with phlegm.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-06-08
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-11-17Pfizer-BioNTech No
22021-12-08Pfizer-BioNTech No

Free text

Release 10 — day 14, dose 1

2021-12-01

Symptoms: Minor head cold symptoms like nasal stuffyness, headache and pressure, sneezing and coughing. Lasted only a few days.

Release 10 — day 35, dose 2

2022-01-17

Symptoms: Minor fever, nasal congestion and coughing with phlegm.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHead discomfort · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDNasopharyngitis · · ✓
SDProductive cough · · ✓
SDPyrexia · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release